Nanomedicine News

RSS

Unique Method to Measure Electrical Charge of Nano Particles

Researchers at the University of Zurich have succeeded in measuring the size and the electrical charge of nano particles by employing a unique method.

30 Jul 2012

University of Calgary Use NanoWizard AFM to Advance Medical Research

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the use of their NanoWizard AFM systems at the Microscopy & Imaging Facility (MI...

From Bruker BioAFM 24 Jul 2012

Nano Suspensions India 2012 Conference to Focus on Challenges in Nano Medicine

CPhI, a part of the pharmaceutical based global level events held by UBM, will be hosting the Nano Suspensions India 2012 conference from August 21 to 22, 2012. Scheduled to take place at the Hotel Fortune Select Manohar, Hyderabad, India, the chief focus of the conference will be on the challenges confronting Quality by Design (QbD), regulatory aspects, stability, efficient scale-up and solubility of nano medicines.

21 Jul 2012

Gold Nanoparticles for Effective Prostate Cancer Treatment

It is known that conventional treatment methods of cancer are accompanied by toxic side effects. This is particularly true of chemotherapy in which chemicals injected into the body are not confined to the tumors alone but attack healthy tissues and vital organs thereby impacting normal bodily functions.

18 Jul 2012

Tekmira’s Lipid Nanoparticle Technology Facilitates Alnylam’s Positive ALN-TTR02 Clinical Results

Tekmira Pharmaceuticals, a company specializing in RNA interference (RNAi) therapeutics, announced that Alnylam Pharmaceuticals has reported its Phase 1 clinical trial results for ALN-TTR02, an RNAi therapeutic that uses Tekmira's lipid nanoparticle delivery platform to target transthyretin (TTR) for TTR-mediated amyloidosis (ATTR) treatment.

17 Jul 2012

Nanolipogels – A Sophisticated Anti-Cancer Drug Delivery System

Yale researchers have developed an anti-cancer drug delivery technique that addresses the challenges in combinatorial drug therapy.

17 Jul 2012

Researchers Design Unique Cancer-Treating Nanomedicine with Reduced Toxicity

A study published in the latest issue of “Proceedings of the National Academy of Sciences (PNAS)” offers a novel approach to cancer treatment by combining supramolecular nanochemistry with drug design.

12 Jul 2012

Merck Licenses PDS Biotechnology’s Versamune Nanotechnology Platform

Merck has inked an exclusive global licensing deal to use PDS Biotechnology’s innovative Versamune nanotechnology platform in Merck’s two investigational antigen-specific cancer immunotherapies that are now in pre-clinical development.

11 Jul 2012

Non-Invasive Method to Effectively Identify Nanoscale Objects and Viruses

Scientists at the Institute for Bioengineering of Catalonia and the University of Barcelona have partnered with the Centro National de Biotecnologia in Madrid and developed a novel technique for identifying nanoscale objects and viruses using an electrostatic force microscope (EFM).

11 Jul 2012

Novavax Presents Preclinical and Clinical Findings for its RSV Vaccine

Novavax, the biopharmaceutical company that develops vaccines for a range of diseases, announced that its Senior Vice President and Chief Medical Officer, Gregory Glenn, M.D., presented the findings of the preclinical and clinical study for Novavax’s respiratory syncytial virus (RSV) vaccine development program at the first conference on Modern Vaccines Adjuvants and Delivery Systems at Copenhagen in Denmark.

From Novavax Inc. 7 Jul 2012